No, penicillin-sensitive Enterococcus faecalis is NOT susceptible to oxacillin.
Enterococcus faecalis, regardless of penicillin susceptibility, is intrinsically resistant to oxacillin and all other penicillinase-resistant penicillins (nafcillin, methicillin). This is a critical microbiological principle that must be understood to avoid treatment failure.
Key Microbiological Distinction
Oxacillin is specifically indicated only for penicillinase-producing staphylococci, not enterococci 1. The FDA label for oxacillin explicitly states it should not be used for organisms susceptible to penicillin G, and more importantly, it has no activity against enterococci regardless of their penicillin susceptibility profile 1.
The confusion often arises because:
- Staphylococci that are "methicillin-susceptible" (MSSA) are treated with oxacillin/nafcillin 2, 3
- Enterococci that are penicillin-susceptible are treated with ampicillin or penicillin G, never oxacillin 2
Appropriate Treatment for Penicillin-Sensitive E. faecalis
For penicillin-susceptible E. faecalis causing serious infections like endocarditis:
First-line regimens 2:
- Ampicillin or penicillin G PLUS gentamicin (for synergy)
- Duration: 4-6 weeks for native valve endocarditis depending on symptom duration
- Ampicillin plus ceftriaxone is an alternative for aminoglycoside-resistant strains 2
Key testing requirements 2:
- Test for penicillin/ampicillin MIC
- Test for high-level gentamicin resistance (>500 μg/mL)
- Test for vancomycin susceptibility
Critical Clinical Pitfall
Never use oxacillin, nafcillin, or any cephalosporin as monotherapy for enterococcal infections, even if the organism is penicillin-susceptible 3. Enterococci are intrinsically resistant to cephalosporins when used alone, though ceftriaxone can be used in combination with ampicillin due to synergistic effects on different penicillin-binding proteins 2.
The distinction between staphylococcal and enterococcal susceptibility patterns is fundamental: oxacillin-class drugs target penicillinase-producing staphylococci, while enterococci require cell wall-active agents (ampicillin/penicillin G) combined with aminoglycosides or ceftriaxone for bactericidal activity 2.